Evidence map›Paper›PMID 27626665›Full record

ArticleCell reports2016

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function.

Kuntal Worah, Till S M Mathan, Thien Phong Vu Manh, Shivakumar Keerthikumar, Gerty Schreibelt, Jurjen Tel, Tjitske Duiveman-de Boer, Annette E Sköld, Annemiek B van Spriel, I Jolanda M de Vries and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. PULSAR: a Foundation Model for Multi-scale and Multi-cellular Biology.bioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Review
  5. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Current issues in molecular biology · 2024
    Review
  6. Guidelines for mouse and human DC generation.European journal of immunology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Kuntal WorahDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Till S M MathanDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Thien Phong Vu ManhCentre d'Immunologie, de Marseille-Luminy, Aix Marseille University UM2, Inserm, U1104, CNRS UMR7280, Cedex 09, 13288 Marseille, France.
Shivakumar KeerthikumarCentre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Gerty SchreibeltDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Jurjen TelDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Tjitske Duiveman-de BoerDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Annette E SköldDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Oncology-Pathology, Karolinska University Hospital Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.
Annemiek B van SprielDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
I Jolanda M de VriesDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Martijn A HuynenCentre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Hans J WesselsRadboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Nijmegen Centre for Mitochondrial Disorders, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Jolein GloerichRadboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands.
Marc DalodCentre d'Immunologie, de Marseille-Luminy, Aix Marseille University UM2, Inserm, U1104, CNRS UMR7280, Cedex 09, 13288 Marseille, France.
Edwin LasonderCentre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; School of Biomedical and Healthcare Sciences, B427 Portland Square, Plymouth University, Drake Circus, Plymouth, Devon PL4 8AA, UK.
Carl G FigdorDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. Electronic address: carl.figdor@radboudumc.nl.
Sonja I BuschowDepartment of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, 3015 CN Rotterdam, the Netherlands. Electronic address: s.buschow@erasmusmc.nl.
Radboud University Medical Center · NLRadboud Institute for Molecular Life Sciences · NLRadboud University Nijmegen · NLCentre d’Immunologie de Marseille-Luminy · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cells (DCs) play a key role in orchestrating adaptive immune responses. In human blood, three distinct subsets exist: plasmacytoid DCs (pDCs) and BDCA3+ and CD1c+ myeloid DCs. In addition, a DC-like CD16+ monocyte has been reported. Although RNA-expression profiles have been previously compared, protein expression data may provide a different picture. Here, we exploited label-free quantitative mass spectrometry to compare and identify differences in primary human DC subset proteins. Moreover, we integrated these proteomic data with existing mRNA data to derive robust cell-specific expression signatures with more than 400 differentially expressed proteins between subsets, forming a solid basis for investigation of subset-specific functions. We illustrated this by extracting subset identification markers and by demonstrating that pDCs lack caspase-1 and only express low levels of other inflammasome-related proteins. In accordance, pDCs were incapable of interleukin (IL)-1β secretion in response to ATP.

Indexed as

BiomarkersCaspase 1Dendritic CellsGene Expression ProfilingGene Expression RegulationHumansInflammasomesProtein Interaction MapsProteomicsReproducibility of ResultsTranscriptomeBiomarkersCaspase 1Inflammasomes

Identifiers

PMID27626665
PMCPMC5039226
OpenAlexW2519093943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.